Bone Biomarkers and Subsequent Survival in Men with Hormone-sensitive Prostate Cancer: Results from the SWOG S1216 Phase 3 Trial of Androgen Deprivation Therapy with or Without Orteronel

Authors: Lara Jr, Primo N., Mayerson, Edward, Gertz, Erik, Tangen, Catherine, Goldkorn, Amir, van Loan, Marta, Hussain, Maha, Gupta, Shilpa, Zhang, Jingsong, Parikh, Mamta, Twardowski, Przemyslaw, Quinn, David I., LeBlanc, Michael, Vogelzang, Nicholas J., Thompson, Ian, Agarwal, Neeraj

Source: In European Urology February 2024 85(2):171-176

Diagnostic Performance and Safety of Positron Emission Tomography with 18F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE)

Authors: Allaf, Mohamad, Andriole, Gerald, Avery, Ryan J., Avril, Norbert, Barker, Helen, Belkoff, Laurence, Budäus, Lars, Cher, Michael L., Chisholm, Diane, Covington, Matthew F., Cox, Ian, Ferrandino, Michael, Fleming, Mark T., Franceschi, Dinko, Gardiner, Peter, Gartrell, Benjamin, Gauden, David, Hasa, Ergela, Hermsen, Rick, Horn, Thomas, Iranpour, Pooya, Jacene, Heather, Jayaratna, Isuru, Joshi, Shreyas S., Kay, Matthew, Kostakoglu, Lale, Kuo, Phillip, Lavely, William, Lokuta, Mary, Lowentritt, Benjamin, Miller, Matthew P., Nix, Jeffrey W., Ogan, Kenneth, Penny, Ross, Piert, Morand, Purysko, Andrei, Ravizzini, Gregory, Saltzstein, Daniel, Savir-Baruch, Bital, Siegel, Barry A., Steuber, Thomas, Twardowski, Przemyslaw, Uchio, Edward, Ulaner, Gary A., Wixom, Jenna M., Yoo, Don, Zukotynski, Katherine, Surasi, Devaki Shilpa, Eiber, Matthias, Maurer, Tobias, Preston, Mark A., Helfand, Brian T., Josephson, David, Tewari, Ashutosh K., Somford, Diederik M., Rais-Bahrami, Soroush, Koontz, Bridget F., Bostrom, Peter J., Chau, Albert, Davis, Phillip, Schuster, David M., Chapin, Brian F.

Source: In European Urology October 2023 84(4):361-370

A phase 1/2 study of nezastomig (anti-PSMA×CD28) with or without cemiplimab (anti–PD-1) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and clear cell renal cell carcinoma (ccRCC).

Authors: Siddiqui, Bilal Ahmed, Carneiro, Benedito A., Stein, Mark N., Zhang, Jingsong, Kelly, William Kevin, Wise, David R, Tsao, Kai, Falchook, Gerald Steven, Twardowski, Przemyslaw, Gao, Xin, Kim, Joseph W., Gelmann, Edward Paul, Thanigaimani, Pradeep, Fang, Fang, Seebach, Frank A., Lowy, Israel, Ingham, Matthew, Kinnaman, Michael David, Sandigursky, Sabina, Miller, Elizabeth

Source: Journal of Clinical Oncology; 2/10/2025 Supplement5, Vol. 43, pTPS293-TPS293, 288p

18F-Fluciclovine Positron Emission Tomography in Men With Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy and Planning to Undergo Salvage Radiation Therapy: Results from LOCATE

Authors: Adler, Lee P., Andriole, Gerald L., Belkoff, Laurence H., Burzon, Daniel, Chau, Albert, Dato, Paul, Duan, Fenghai, Farwell, Michael, Fogelson, Stephen, Gardiner, Peter, Hanna, Lucy, Hoffman, John M., Intenzo, Charles, Josephson, David, Kaminetsky, Jed, Kipper, Michael, Kostakoglu, Lale, Krynyckyi, Borys, Linder, Karen E., Mahmood, Umar, Marques, Helga, Mankoff, David, McConathy, Jonathan, Melnick, John, Miller, Matthew P., Oh, William, Philips, Shaile, Rose, Judith, Savir-Baruch, Bital, Schuster, David M., Siegel, Barry A., Stevens, Daniel J., Tewari, Ashutosh, Twardowski, Przemyslaw, Ward, Penelope, Wasserman, Martha, Weick, Sharon, (Michael) Yu, Jian Q., Solanki, Abhishek A., Liauw, Stanley L., Michalski, Jeff, Tward, Jonathan D., Vapiwala, Neha, Teoh, Eugene J.

Source: In Practical Radiation Oncology September-October 2020 10(5):354-362

Reduction of myeloid‐derived suppressor cells in prostate cancer murine models and patients following white button mushroom treatment.

Authors: Wang, Xiaoqiang, Ma, Shoubao, Twardowski, Przemyslaw, Lau, Clayton, Chan, Yin S., Wong, Kelly, Xiao, Sai, Wang, Jinhui, Wu, Xiwei, Frankel, Paul, Wilson, Timothy G., Synold, Timothy W, Presant, Cary, Dorff, Tanya, Yu, Jianhua, Sadava, David, Chen, Shiuan

Source: Clinical & Translational Medicine; Oct2024, Vol. 14 Issue 10, p1-24, 24p

Subject Terms: SUPPRESSOR cells, CYTOTOXIC T cells, KILLER cells, IMMUNE checkpoint inhibitors, MYELOID-derived suppressor cells, PROSTATE cancer

Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on Outcomes

Authors: Galsky, Matthew D., Wang, Huan, Hahn, Noah M., Twardowski, Przemyslaw, Pal, Sumanta K., Albany, Costantine, Fleming, Mark T., Starodub, Alexander, Hauke, Ralph J., Yu, Menggang, Zhao, Qianqian, Sonpavde, Guru, Donovan, Michael J., Patel, Vaibhav G., Sfakianos, John P., Domingo-Domenech, Josep, Oh, William K., Akers, Nicholas, Losic, Bojan, Gnjatic, Sacha, Schadt, Eric E., Chen, Rong, Kim-Schulze, Seunghee, Bhardwaj, Nina, Uzilov, Andrew V.

Source: In European Urology May 2018 73(5):751-759

Validation of the Association of RECIST Changes With Survival in Men With Metastatic Castration-Resistant Prostate Cancer Treated on SWOG Study S0421

Authors: Sonpavde, Guru, Pond, Gregory R., Plets, Melissa, Tangen, Catherine M., Hussain, Maha H.A., Lara, Primo N., Jr., Goldkorn, Amir, Garzotto, Mark G., Mack, Philip C., Higano, Celestia S., Vogelzang, Nicholas J., Thompson, Ian M., Jr., Twardowski, Przemyslaw W., Van Veldhuizen, Peter J., Jr., Agarwal, Neeraj, Carducci, Michael A., Monk, J. Paul, Quinn, David I.

Source: In Clinical Genitourinary Cancer December 2017 15(6):635-641

Outcomes and toxicity of 313 prostate cancer patients receiving helical tomotherapy after radical prostatectomy

Authors: Jensen, Lindsay, Yuh, Bertram, Wong, Jeffrey Y.C., Schultheiss, Timothy, Cheng, Jonathan, Ruel, Nora, Twardowski, Przemyslaw, Sampath, Sagus ^*

Source: In Advances in Radiation Oncology October-December 2017 2(4):597-607

Impact of intra‐tumoral immunity on predicting response and survival after neoadjuvant cisplatin‐based chemotherapy in patients with muscle invasive bladder cancer.

Authors: Mendoza‐Valderrey, Alberto, Choe, Jane, Kessler, Daria M., Jimenez, Gianna, Li, Xinmin, Kolker, Steven, Allen, Warren, Linehan, Jennifer A., Twardowski, Przemyslaw W., Ascierto, Maria Libera

Source: Cancer Medicine; Aug2024, Vol. 13 Issue 15, p1-12, 12p

Subject Terms: PATHOLOGIC complete response, TREATMENT effectiveness, B cells, T cells, IMMUNE checkpoint proteins, BLADDER cancer

The Mechanism of Cancer-Mediated Conversion of Plasminogen to the Angiogenesis Inhibitor Angiostatin

Authors: Gately, Stephen, Twardowski, Przemyslaw, Stack, M. Sharon, Cundiff, Deborah L., Grella, Davida, Castellino, Francis J., Enghild, Jan, Kwaan, Hau C., Lee, Francis, Kramer, Robert A., Volpert, Olga, Bouck, Noel, Soff, Gerald A.

Source: Proceedings of the National Academy of Sciences of the United States of America, 1997 Sep . 94(20), 10868-10872.

Access URL: https://www.jstor.org/stable/43431

Time from definitive therapy to onset of metastatic disease predicts outcomes in men with metastatic hormone sensitive prostate cancer

Authors: Hahn, Andrew W., Stenehjem, David D., Alex, Anitha B., Gill, David M., Cheng, Heather H., Kessler, Elizabeth R, Chittoria, Namita, Twardowski, Przemyslaw, Vaishampayan, Ulka, Agarwal, Neeraj

Source: In Urologic Oncology: Seminars and Original Investigations June 2019 37(6):352-352

Papillary Renal Cell Carcinoma: Current Progress and Future Directions

Authors: Twardowski, Przemyslaw W., Mack, Philip C., Lara, Primo N., Jr.

Source: In Clinical Genitourinary Cancer April 2014 12(2):74-79

Impact of 18 F-flotufolastat PET on management of patients with recurrent prostate cancer: Data from the SPOTLIGHT study.

Authors: Twardowski, Przemyslaw

Source: Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p38-38, 235p

Baseline CD8 lymph node avidity with 89-Zr-crefmirlimab in patients with metastatic renal cell carcinoma and response to IO therapy.

Authors: Zang, Peter D., Twardowski, Przemyslaw, Chen, Delphine L, Hall, Evan Thomas, Hays, David, Wilson, Ian, Schmiedehausen, Kristin, Ferris, Michael, Le, William, Postow, Michael A., Pal, Sumanta Kumar

Source: Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p375-375, 140p

Clinical outcome in patients receiving systemic therapy for metastatic sarcomatoid renal cell carcinoma: A retrospective analysis☆

Authors: Pal, Sumanta K., Jones, Jeremy O., Carmichael, Courtney, Saikia, Junmi, Hsu, Joanne, Liu, Xueli, Figlin, Robert A., Twardowski, Przemyslaw, Lau, Clayton

Source: In Urologic Oncology: Seminars and Original Investigations November 2013 31(8):1826-1831

Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial

Authors: Quinn, David I, Tangen, Catherine M, Hussain, Maha, Lara, Primo N, Jr, Goldkorn, Amir, Moinpour, Carol M, Garzotto, Mark G, Mack, Philip C, Carducci, Michael A, Monk, J Paul, Twardowski, Przemyslaw W, Van Veldhuizen, Peter J, Agarwal, Neeraj, Higano, Celestia S, Vogelzang, Nicholas J, Thompson, Ian M, Jr

Source: In Lancet Oncology August 2013 14(9):893-900

Paclitaxel-Based High-Dose Chemotherapy with Autologous Stem Cell Rescue for Relapsed Germ Cell Tumor: Clinical Outcome and Quality of Life in Long-Term Survivors

Authors: Pal, Sumanta K., Yamzon, Jonathan, Sun, Virginia, Carmichael, Courtney, Saikia, Junmi, Ferrell, Betty, Frankel, Paul, Hsu, JoAnn, Twardowski, Przemyslaw, Stein, Cy A., Margolin, Kim

Source: In Clinical Genitourinary Cancer June 2013 11(2):121-127

Impact of age on treatment trends and clinical outcome in patients with metastatic renal cell carcinoma

Authors: Pal, Sumanta K., Hsu, JoAnn, Hsu, Sarah, Hu, Jensen, Bergerot, Paulo, Carmichael, Courtney, Saikia, Junmi, Liu, Xueli, Lau, Clayton, Twardowski, Przemyslaw, Figlin, Robert A., Yuh, Bertram E.

Source: In Journal of Geriatric Oncology April 2013 4(2):128-133

Synaptophysin expression on circulating tumor cells in patients with castration resistant prostate cancer undergoing treatment with abiraterone acetate or enzalutamide

Authors: Pal, Sumanta K., He, Miaoling, Chen, Lin, Yang, Lixin, Pillai, Raju, Twardowski, Przemyslaw, Hsu, JoAnn, Kortylewski, Marcin, Jones, Jeremy O. ^⁎

Source: In Urologic Oncology: Seminars and Original Investigations April 2018 36(4):162-162

Germline and somatic testing for homologous repair deficiency in patients with prostate cancer (part 1 of 2)

Authors: Armstrong, Andrew J., Taylor, Amy, Haffner, Michael C., Abida, Wassim, Bryce, Alan H., Karsh, Lawrence I., Tagawa, Scott T., Twardowski, Przemyslaw, Serritella, Anthony V., Lang, Joshua M.

Source: Prostate Cancer and Prostatic Diseases; 20240101, Issue: Preprints p1-10, 10p